Free Trial
NASDAQ:QLGN

Qualigen Therapeutics (QLGN) Stock Price, News & Analysis

Qualigen Therapeutics logo
$3.26 0.00 (-0.03%)
Closing price 07/3/2025 03:10 PM Eastern
Extended Trading
$3.26 0.00 (-0.09%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Qualigen Therapeutics Stock (NASDAQ:QLGN)

Key Stats

Today's Range
$3.16
$3.27
50-Day Range
$3.26
$3.98
52-Week Range
$2.85
$29.44
Volume
4,783 shs
Average Volume
107,746 shs
Market Capitalization
$5.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive QLGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

QLGN Stock News Headlines

Qualigen Therapeutics, Inc. (QLGN) - Yahoo Finance
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

QLGN Stock Analysis - Frequently Asked Questions

Qualigen Therapeutics' stock was trading at $4.21 at the start of the year. Since then, QLGN stock has decreased by 22.6% and is now trading at $3.2590.

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) posted its quarterly earnings data on Tuesday, August, 15th. The company reported ($34.50) EPS for the quarter, missing the consensus estimate of ($26.00) by $8.50. The business earned $1.63 million during the quarter, compared to the consensus estimate of $1.60 million.

Qualigen Therapeutics's stock reverse split on the morning of Tuesday, November 5th 2024.The 1-50 reverse split was announced on Friday, November 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, November 4th 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of QLGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Qualigen Therapeutics investors own include Predictive Oncology (POAI), Ford Motor (F), Zomedica (ZOM), Bank of America (BAC), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
8/15/2023
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QLGN
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.98 million
Price / Cash Flow
N/A
Book Value
($20.31) per share
Price / Book
-0.16

Miscellaneous

Free Float
723,000
Market Cap
$5.34 million
Optionable
Not Optionable
Beta
0.03
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:QLGN) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners